Publikationen 1999

Substantial Increase in the Breast Conservation Rate Between 1984 and 1997 in 3,464 Patients Randomized in Trials of the Austrian Breast Cancer Study Group (ABCSG)

Gnant M, Jakesz R, Hausmaninger H, Samonigg H, Kubista E, Depisch D, Fridrik M, Stierer M, Steger G, Kolb R, Jatzko G, Hofbauer F, Reiner G, Luschin-Ebengreuth G

American Society of Clinical Oncology

Download Publikation


Comparison of Adjuvant Therapy with Tamoxifen and Goserelin vs. CMF in Premenopausal Stage I and II Hormone-Responsive Breast Cancer Patients: Four-Year Results of Austrian Breast Cancer Study Group (ABCSG)

Jakesz R, Hausmaninger H, Samonigg H, Kubista E, Depisch D, Fridrik M, Stierer M, Gnant M, Steger G, Kolb R, Jatzko G, Hofbauer F, Reiner G, Luschin-Ebengreuth G

American Society of Clinical Oncology

Download Publikation


Indikationen und Kontraindikationen für brusterhaltende chirurgische Therapie

Jakesz R, Gebhard B, Gnant M, Taucher S

Der Chirurg 01/1999; 70(4):394-399.

Download Publikation


Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node-Positive Breast Cancer

Jakesz R, Hausmaninger H, Haider K, Kubista E, Samonigg H, Gnant M, Manfreda D, Tschurtschenthaler G, Kolb R, Stierer M, Fridrik M, Mlineritsch B, Steindorfer P,  Mittlböck M, Steger G

Journal of Clinical Oncology 1999 Jun;17(6):1701-9.

Download Publikation


Derzeitiger Stellenwert der adjuvanten medikamentösen Ovarektomie

Jakesz R

Onkologie 1999;22(suppl 2):12-13.

Download Publikation


Combination Goserelin and Tamoxifen is more effective than CMF in premenopausal patients with hormone-receptor tumors in a multicenter trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

Jakesz R, Gnant M, Hausmaninger H, Samonigg H, Kubista E, Steindorfer P, Kwasny W, Tausch C, Steger G

San Antonio Breast Cancer Symposium

Download Publikation


Prognostic significance of mutations in the p53 gene, particulary in the zinc-Binding domains, in lymph node- and steroid receptor positive breast cancer patients

Kucera E, Speiser P, Gnant M, Szabo L, Samonigg H, Hausmaninger H, Mittlböck M, Fridrik M, Seifert M, Kubista E, Reiner A, Zeillinger R, Jakesz R

European Journal of Cancer 1999 Mar;35(3):398-405.

Download Publikation


Tamoxifen vs. Tamoxifen Plus Aminoglutethimide for Stage I and II Receptor-Positive Postmenopausal Node-Negative or Node-Positive Breast Cancer Patients: Four-Year Results of a Randomized Trial of the Austrian Breast Cancer Study Group (ABCSG)

Samonigg H, Jakesz R, Hausmaninger H, Depisch D, Fridrik M, Stierer M, Steger G, Kolb R, Hofbauer F, Reiner G, Schmid M

American Society of Clinical Oncology

Download Publikation